Chitosan (CS) and hydroxyapatite (HA) bioactive molecules have been grafted onto commercially pure titanium surfaces (cpTi) to promote osteoblast adhesion and bone growth. The major challenge of this type of grafting is the attachment of the CS/HA biocomposite to the cpTi surface. In this study cpTi is biofunctionalized with CS/HA biocomposite material via silanization and the coated specimens were characterized using X-ray diffraction (XRD), scanning electron microscopy (SEM), water contact angle measurement and attenuated total reflectance-Fourier transform infrared (ATR-FTIR). The cpTi specimens were further evaluated for their in vitro bioactivity, hemocompatibility, protein adsorption and cell viability. The SEM micrographs showed uniform coatings adhered on cpTi specimens. The XRD and ATR-FTIR confirmed the presence of CS and HA on the cpTi specimens. The coated specimens showed improved in vitro bioactivity and hemocompatibilty along with enhanced adsorption of specific proteins. The cell viability studies showed non-cytotoxic nature of all the specimens and exhibited greater cell viability in the titanium CS/HA specimens. Hence, the studies showed that functionalized cpTi with covalent coating of CS/HA has significant potential in biomedical device implantation with improved bioactive properties.